Mount Sinai Beth Israel /ID# 216712 — New York, New York

Mount Sinai Beth Israel /ID# 216712 is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Beth Israel /ID# 216712 has participated in 1 clinical trials.

Therapeutic areas: Parkinson's Disease (PD).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Beth Israel /ID# 216712?

Mount Sinai Beth Israel /ID# 216712 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Beth Israel /ID# 216712 conducted?

Mount Sinai Beth Israel /ID# 216712 has 1 clinical trials on record. Their work covers Parkinson's Disease (PD).

Is Mount Sinai Beth Israel /ID# 216712 accredited by Crixeo Health?

Mount Sinai Beth Israel /ID# 216712 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Beth Israel /ID# 216712?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.